|
Pronunciation |
|
(e
NAL a pril & hye droe klor oh
THYE a zide) |

|
|
U.S. Brand
Names |
|
Vaseretic®
10-25 |

|
|
Generic
Available |
|
No |

|
|
Canadian Brand
Names |
|
Vaseretic® |

|
|
Synonyms |
|
Hydrochlorothiazide and Enalapril |

|
|
Pharmacological Index |
|
Antihypertensive Agent, Combination |

|
|
Use |
|
Treatment of hypertension |

|
|
Pregnancy Risk
Factor |
|
C/D (2nd and 3rd trimesters) |

|
|
Usual Dosage |
|
Oral: Dose is individualized |

|
|
Cardiovascular
Considerations |
|
Combination therapy for the treatment of hypertension should be
individualized for each patient. Potential advantages for enalapril and
hydrochlorothiazide combination therapy may include improved compliance and
synergistic reductions in blood pressure with an accompanied reduction in side
effects. ACE inhibitors and thiazides are also standard therapy for left
ventricular systolic dysfunction. |

|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |

|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |

|
|
Patient
Information |
|
See individual agents. Pregnancy precautions: Inform prescriber if
you are or intend to be pregnant. |

|
|
Dosage Forms |
|
Tablet:
Enalapril maleate 10 mg and hydrochlorothiazide 25 mg
|

|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|